Faster trials.
Broader access.
One AI-powered platform.

Introducing your competitive advantage. Inato’s AI-powered platform connects you to engaged sites at scale, so you can accelerate drug development and ultimately bring care to the patients who need it most.

inato app mockup image

Innovating with
Forward-Thinking Pharma Leaders

We co-develop our technology with forward-thinking pharma and site leaders to ensure every trial is faster, more efficient, and more inclusive.

Why Leading Sponsors Partner with Inato

Partner with proven sites

Work with motivated, high-performing sites that match your protocol and help you reach underrepresented communities.

Reach more patients, everywhere

Connect with 5,500+ committed research sites across 50+ countries to reach the right patients, faster.

Everything in one platform

From early planning to patient enrollment, simplify how you run trials, all in one place.

How we do it

Inato’s platform is built to support you from early planning to enrollment.  Make faster, more informed decisions with our co-developed AI capabilities and site insights at scale.

01

Early planning

Use site insights at scale to inform your strategy and design trials that are both inclusive and efficient.

02

AI  site selection

Confidently select the mix of sites that best aligns with your trial goals, powered by AI insights that guide better decisions.

03

AI patient pre‑screening

Reduce site burden, accelerate chart review, and gain visibility with real-time insights by site, trial, and indication.

How it all
works together

Each step powers the next, creating a seamless flow from planning to performance. Sponsors gain early protocol insights, engage high-performing sites faster, and track real-time site performance to optimize every stage of the trial.

Real impact and proven results

Events

SCOPE Orlando Recap: How AI Can Transform Patient Recruitment and Enrollment

-
Inato
5
min
February 20, 2025
SCOPE Orlando Recap: How AI Can Transform Patient Recruitment and Enrollment
Sponsors

Phase III COPD Case Study: 85% of patients were diverse

Events

SCOPE Europe Recap: Building Trust & Boosting Trial Outcomes

-
Inato
5
min
November 5, 2024
SCOPE Europe Recap: Building Trust & Boosting Trial Outcomes
Sponsors

Oncology Case Study: 66% faster enrollment time

Sites

Q+A(I): Behind-the-scenes of Inato patient pre-screening with Inato’s Lead AI Engineer

-
Inato
5
min
March 20, 2025
Q+A(I): Behind-the-scenes of Inato patient pre-screening with Inato’s Lead AI Engineer

Join the global platform driving faster, more accessible trials.